Provenienza dei contatti di primo grado di Ali Tavassoli
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Curve Therapeutics Ltd.
Curve Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Curve Therapeutics Ltd. operates as a drug-discovery company. It engages on the development of innovative technologies to address undruggable disease-modifying targets, with an in-house focus on cancer. The company was founded in 2019 and is headquartered in London, the United Kingdom.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ali Tavassoli tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
ACTIVE BIOTECH AB | Biotechnology | Corporate Officer/Principal | |
University of Leeds | College/University | Doctorate Degree | |
ABLYNX | Biotechnology | Corporate Officer/Principal | |
Health Protection Agency | General Government | Corporate Officer/Principal | |
Karus Therapeutics Ltd.
Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Loughborough University | College/University | Doctorate Degree Undergraduate Degree | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Private Equity Investor | |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Miscellaneous Commercial Services | Director/Board Member | |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Founder | |
Actinova Ltd.
Actinova Ltd. Pharmaceuticals: MajorHealth Technology Part of Active Biotech AB, Actinova Ltd. is a British company that provides research and development services to the biotechnology sectors and also develops drugs and vaccines. The company is based in Cambridge, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Eternygen GmbH
Eternygen GmbH Pharmaceuticals: MajorHealth Technology Eternygen GmbH engages in the research and development of drugs. It develops new drugs for dietary-related metabolic diseases which include obesity, diabetes mellitus and fatty liver. The company was founded by Marco J. Janezic in June 2012 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Epidarex Capital Partners LLC
Epidarex Capital Partners LLC Investment ManagersFinance Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland. | Investment Managers | Private Equity Investor | |
Actigen Ltd.
Actigen Ltd. BiotechnologyHealth Technology Actigen Ltd. provides biological products. The private company is based in Cambridge, UK. | Biotechnology | Corporate Officer/Principal | |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Enterprise Therapeutics Ltd. operates as a drug discovery company that engages in the research and development of therapies for the treatment of respiratory diseases. It focuses on developing therapies for chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company was founded by John Mervyn David Store in May 2014 and is headquartered in Falmer, the United Kingdom. | Biotechnology | Director/Board Member | |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Biotechnology | Director of Finance/CFO | |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Argonaut Therapeutics Ltd.
Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Argonaut Therapeutics Ltd. develops novel epigenetic therapies. It targets abnormal arginine methylation in cancer. The company was founded by Nicholas La Thangue and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman | |
Adorx Therapeutics Ltd.
Adorx Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adorx Therapeutics Ltd. provides biotechnology, health care and therapeutics services. The company is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Epsilogen Ltd.
Epsilogen Ltd. Pharmaceuticals: MajorHealth Technology Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom. | Pharmaceuticals: Major | Chairman | |
Lunac Therapeutics Ltd.
Lunac Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lunac Therapeutics Ltd. engages in the identification and development of anticoagulants. The company was founded by Helen Philippou and Richard Foster on April 18, 2018 and is headquartered in Leeds, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Leucid Bio Ltd. is a clinical-stage biotechnology company based in London, UK. The British company develops novel, lateral car cell therapies for the treatment of refractory cancers, with a focus on developing next-generation cell therapies for the benefit of individuals with hard-to-treat solid tumors. The company's operations are based at Guys Hospital, enabling them to maintain a patient-centric focus. Leucid's goal is to develop CAR-T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers. Leucid was established to translate 20 years of Kings College research in the CAR-T field and is led by a highly experienced management team, including scientific founder John Maher. Filippo Joseph Petti has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
AviadoBio Ltd.
AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Epidarex Exeed Ltd.
Epidarex Exeed Ltd. Miscellaneous Commercial ServicesCommercial Services Epidarex Exeed Ltd. is a British biotechnology company that specializes in research and experimental development. The company is based in Edinburgh, UK. The company was founded in 2019 by Elizabeth Ann Roper and Henning Steinhagen, with Henning Steinhagen serving as the CEO since its inception. | Miscellaneous Commercial Services | Director/Board Member | |
Reachora Ltd.
Reachora Ltd. Data Processing ServicesTechnology Services Reachora Ltd., through its platform wondr medical, aims to accelerate medical learning and discovery by creating the world's most connected medical network. The company is based in London, UK. The platform is built around healthcare professionals who are driven by curiosity to discover more, from breakthrough research to advances in best practice, and from meeting collaborators to learning from mentors and peers. Wondr medical helps doctors and medical professionals across the world collaborate, connect, and discover medical information. The British company was founded in 2016 by Justin Edgar Rees Davies, who has been the CEO since 2016. | Data Processing Services | Director/Board Member | |
Clyde Biosciences Ltd.
Clyde Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Clyde Biosciences Ltd. provides developmental drug testing services. It offers drug screening, toxicity data analysis, direct measurements, and drug induced changes investigation services. Its services include calcium, voltage, contractility, in silico modeling, CiPA studies and bespoke R&D. The company was founded by Margaret Anne Craig, Godfrey Smith, Francis Burton, and Jon Cooper on March 9, 2012 and is headquartered in Glasgow, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
Regno Unito | 21 |
Stati Uniti | 3 |
Germania | 3 |
Svezia | 2 |
Belgio | 2 |
Settori
Health Technology | 14 |
Commercial Services | 8 |
Finance | 3 |
Consumer Services | 3 |
Government | 2 |
Posizioni
Director/Board Member | 17 |
Corporate Officer/Principal | 6 |
Chairman | 4 |
Chief Executive Officer | 3 |
Undergraduate Degree | 3 |
Contatti più connessi
Insiders | |
---|---|
Peter Finan | 14 |
Simon Kerry | 11 |
Shahzad Malik | 3 |
Julia Jones | 3 |
Diana Galpin | 1 |
- Borsa valori
- Insiders
- Ali Tavassoli
- Connessioni Società